Rallybio Corporation (RLYB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -7.98M | -4.68M | -6.55M | -8.38M | -10.21M | -9.86M | -13.54M | -10.42M | -15.46M | -11.64M | -16.47M | -13.38M |
| Operating CF Margin % | -3763.21% | -2107.66% | -3089.62% | -3952.36% | -4813.68% | -25952.63% | -4530.1% | -3484.28% | - | -5107.46% | - | - |
| Operating CF Growth % | 21.82% | 52.56% | 51.64% | 19.57% | 33.98% | 15.31% | 17.76% | 22.16% | 17.63% | 23.71% | -11.78% | 1.25% |
| Net Income | -8.28M | -5.85M | 16.02M | -9.7M | -9.44M | -11.04M | -11.47M | -16.24M | -19.03M | -20.24M | -18.37M | -18.63M |
| Depreciation & Amortization | 3K | 3K | 35K | 26K | 28K | 30K | 32K | 34K | 35K | 36K | 37K | 38K |
| Stock-Based Compensation | 0 | 774K | 1.05M | 1.61M | 1.88M | 1.96M | 2.03M | 1.92M | 2.09M | 2.55M | 2.63M | 2.69M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.1M | 648K | 0 |
| Other Non-Cash Items | 562K | -97K | -22.46M | 134K | 377K | 114K | 963K | 71K | 146K | 2.05M | -703K | -617K |
| Working Capital Changes | -265K | 493K | -1.19M | -450K | -3.05M | -925K | -5.1M | 3.8M | 1.3M | 6.06M | -713K | 3.13M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 814K | -143K | 150K | -281K | 122K | -305K | -635K | 748K | -506K | 524K | -236K | -92K |
| Cash from Investing | 17.9M | 3.92M | 29.23M | 3.04M | 11.08M | -1.57M | 22.2M | 2.6M | 10.26M | 16.91M | 3.07M | 6.21M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12K | -3.07K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | 5.26% | - | - |
| Acquisitions | 0 | -1M | 20M | 1M | -1M | 0 | 1.5M | -750K | -750K | -750K | -750K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 1M | 0 | -1.5M | 0 | 0 | -3.5M | 0 | 0 | 750K | 3.07K | 0 |
| Cash from Financing | 3K | 6K | 0 | 10K | 0 | 18K | -11K | 5.19M | 0 | 72K | 0 | 210K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 3K | 6K | 0 | 10K | 0 | 18K | -11K | 5.19M | 0 | 72K | 0 | 210K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 10K | 0 | 18K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 9.93M | -748K | 22.68M | -5.33M | 876K | -11.42M | 8.65M | -2.63M | -5.19M | 5.34M | -13.4M | -6.96M |
| Free Cash Flow | -7.98M | -4.68M | -6.55M | -8.38M | -10.21M | -9.86M | -13.54M | -10.42M | -15.46M | -11.66M | -16.47M | -13.38M |
| FCF Margin % | -3763.21% | -2107.66% | -3089.62% | -3952.36% | -4813.68% | -25952.63% | -4530.1% | -3484.28% | - | -5112.72% | - | - |
| FCF Growth % | 21.82% | 52.56% | 51.64% | 19.57% | 33.98% | 15.4% | 17.78% | 22.16% | 17.63% | 23.63% | -11.77% | 1.36% |
| FCF per Share | -1.40 | -0.89 | -1.16 | -1.49 | -1.82 | -1.77 | -2.43 | -1.89 | -3.03 | -2.29 | -3.25 | -2.65 |
| FCF Conversion (FCF/Net Income) | 0.96x | 0.80x | -0.41x | 0.86x | 1.08x | 0.89x | 1.18x | 0.64x | 0.81x | 0.58x | 0.90x | 0.72x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |